Finally, therapeutic treatment with Nec-1s reduced mortality, lung viral load and CNS manifestation in vivo in ACE2 transgenic mice infected with SARS-CoV-2, a severe COVID-19 animal model. This evidence concerns the gene ACE2 and COVID-19.